S&P 500
5.156,01 +28,22 (+0,55%) Nasdaq
16.261,15 +104,82 (+0,65%) NIKKEI 225
38.236,07 -38,03 (-0,10%) Dólar/Euro
1,0779 +0,0013 (+0,12%) Petróleo Brent
83,47 +0,51 (+0,61%) Bitcoin EUR
59.008,57 -672,84 (-1,13%)
Mesa Laboratories, Inc. (MLAB)
Mesa Laboratories, Inc.
12100 West Sixth Avenue
Lakewood, CO 80228
United States
303 987 8000
https://www.mesalabs.com
Sector(es): Technology
Sector: Scientific & Technical Instruments
Empleados a tiempo completo: 698
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Gary M. Owens | CEO, President & Director | 1,02M | N/A | 1968 |
| Mr. John V. Sakys | VP, CFO & Chief Accounting Officer | 551,4k | 1,11M | 1969 |
| Mr. Brian David Archbold | Senior Vice President of Continuous Improvement | 485,59k | N/A | 1976 |
Descripción
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Gobierno corporativo
El ISS Governance QualityScore de Mesa Laboratories, Inc., a día 1 de mayo de 2024, es 6. Las puntuaciones base son Auditoría: 9; Tablero: 4; Derechos de los accionistas: 3; Compensación: 8.
